Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TapImmune Inc (NASDAQ:TPIV)

4.37
Delayed Data
As of Mar 28
 0.00 / 0.00%
Today’s Change
3.32
Today|||52-Week Range
9.83
+12.63%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.000.000.000.00--
 
Operating ExpensesGross Income0.000.000.000.00--
General Expenses2.7M3.4M6.2M8.5M
 
 
 
 
 
Research And Development661.6K189.0K1.7M3.8M
 
 
 
 
 
Total Operating Expenses2.7M3.4M6.2M8.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.7M-3.4M-6.2M-8.5M
 
 
 
 
 
Extraordinary Credit1.5M581.000.005.9M
 
 
 
 
Extraordinary Charge-2.7M-26.9M-27.9M-135.6K
 
 
 
 
 
Interest Expense On Debt1.8M575.5K10.9K0.00
 
 
 
 
Other Expenses5.9K-53.0K-23.9K1.8K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.5M-30.9M-34.1M-2.5M
 
 
 
 
 
Net Income-5.5M-30.9M-34.1M-2.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS94.7K1.3M3.7M6.9M
 
 
 
 
 
Shares To Calculate EPS Diluted94.7K1.3M3.7M7.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$58.44-$24.00-$9.36-$0.72
 
 
 
 
 
EPS Diluted-$58.44-$24.00-$9.36-$0.72